Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 301-305 |
Seitenumfang | 5 |
Fachzeitschrift | Journal of Biopharmaceutical Statistics |
Jahrgang | 13 |
Ausgabenummer | 2 |
Publikationsstatus | Veröffentlicht - 4 Jan. 2003 |
Abstract
The identification of the minimum effective dose for both the primary and secondary endpoint under a priori importance ordering assumption is described. Stepwise testing procedures, which conditionally test each elementary hypotheses at level α, but control the experimentwise Type I error rate, can be used.
ASJC Scopus Sachgebiete
- Mathematik (insg.)
- Statistik und Wahrscheinlichkeit
- Pharmakologie, Toxikologie und Pharmazie (insg.)
- Pharmakologie
- Medizin (insg.)
- Pharmakologie (medizinische)
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Journal of Biopharmaceutical Statistics, Jahrgang 13, Nr. 2, 04.01.2003, S. 301-305.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Analyzing randomized dose finding studies with a primary and a secondary endpoint
AU - Hothorn, Ludwig A.
AU - Wassmer, Gernot
PY - 2003/1/4
Y1 - 2003/1/4
N2 - The identification of the minimum effective dose for both the primary and secondary endpoint under a priori importance ordering assumption is described. Stepwise testing procedures, which conditionally test each elementary hypotheses at level α, but control the experimentwise Type I error rate, can be used.
AB - The identification of the minimum effective dose for both the primary and secondary endpoint under a priori importance ordering assumption is described. Stepwise testing procedures, which conditionally test each elementary hypotheses at level α, but control the experimentwise Type I error rate, can be used.
KW - Dose finding trial
KW - Intersection-union test
KW - Multiple endpoints
UR - http://www.scopus.com/inward/record.url?scp=0037273486&partnerID=8YFLogxK
U2 - 10.1081/BIP-120019273
DO - 10.1081/BIP-120019273
M3 - Article
C2 - 12729396
AN - SCOPUS:0037273486
VL - 13
SP - 301
EP - 305
JO - Journal of Biopharmaceutical Statistics
JF - Journal of Biopharmaceutical Statistics
SN - 1054-3406
IS - 2
ER -